$APTX News Article - Aptinyx Announces Results of Phase 2 Fibromyalgia Study of NYX-2925 Have Been Selected for Late-Breaking Presentation at the American College of Rheumatology Annual Meeting
https://marketwirenews.com/news-releases/apti...25454.html